The efficacy and safety of Yokukansan for BPSD in Alzheimer's disease: a randomized, double-blind, placebo-control trial.
Phase of Trial: Phase II
Latest Information Update: 13 May 2016
At a glance
- Drugs TJ 54 (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- 27 Mar 2013 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 24 Oct 2011 Actual initiation date (Feb 2011) added as reported by University Hospital Medical Information Network - Japan
- 24 Oct 2011 Status changed from not yet recruiting to recruiting as reported by UMIN.